Understanding the pharmacokinetics parameter of colistin methanesulfonate sodium (CMS) and colistin is needed to optimize the dosage regimen in critically ill patients. However, there is a scarcity of pharmacokinetics parameters in this population. This review provides a comprehensive understanding of CMS and colistin pharmacokinetics parameters in this population. The relevant studies published in English that reported on the pharmacokinetics of CMS and colistin from 2000 until 2020 were systematically searched using the PubMed and Scopus electronic databases. Reference lists of articles were reviewed to identify additional studies. A total of 252 citation titles were identified, of which 101 potentially relevant abstracts were screened, and 25 full-text articles were selected for detailed analysis. Of those, 15 studies were included for the review. This review has demonstrated vast inter-study discrepancies in colistin plasma concentration and the pharmacokinetics parameter estimates. The discrepancies might be due to complex pathophysiological changes in the population studied, differences in CMS brand used, methodology, and study protocol. Application of loading dose of CMS and an additional dose of CMS after dialysis session was recommended by some studies. In view of inter-patient and intra-patient variability in colistin plasma concentration and pharmacokinetics parameters, personalized colistin dosing for this population is recommended.
20 July 2020 in Journal of Liquid Chromatography & Related Technologies
Colistin is an old antibiotic reintroduced in response to an increased incidence of multi-resistant Gram-negative bacterial infections. It has a narrow therapeutic window, and dose optimization is required. Dose optimization requires accurate method of measurement. The goal of this manuscript is to review previously developed methods, their advantages and disadvantages, and problems to be addressed for colistin assay in pharmacokinetic studies. Articles published in English from December 2000 to 2019 were systematically searched using PubMed and Scopus. Reference lists of articles were reviewed to identify additional studies. A total of 220 articles were identified, 26 of which met the inclusion criteria in this review. Of those, six articles were found to contain relevant methods for pharmacokinetic analysis of colistin in subjects treated with colistimethate sodium. The report describes sample preparation techniques, analytical methods used for the determination, and quantification of colistimethate sodium and colistin, mobile phase use, and problems encountered. One of the greatest challenges in colistin bioanalysis is ensuring the stability of colistimethate sodium in vivo and in vitro prior analysis. This review also highlights the precautionary measures to minimize hydrolysis of colistimethate sodium during experiments.